COSMIC, chemotherapy plus ofatumumab at standard or mega‐dose in chronic lymphocytic leukaemia, a phase II randomised study

Autor:	Adrian Bloor, Anna Hockaday, Amit C. Nathwani, David Allsup, Peter Hillmen, Andy C. Rawstron, Talha Munir, Dena R. Howard, Shankara Paneesha, Jamie B. Oughton, David Phillips, Jake Emmerson, Deborah Turner
Rok vydání:	2021
Předmět:	Oncology Chemotherapy medicine.medical_specialty Lymphocytic leukaemia business.industry medicine.medical_treatment Hematology Mega Ofatumumab Minimal residual disease Clinical trial chemistry.chemical_compound chemistry Internal medicine Medicine business
Zdroj:	British Journal of Haematology. 194:646-650
ISSN:	1365-2141 0007-1048
DOI:	10.1111/bjh.17526
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::353da9ccdd0048d06aa4d84f04488d1b https://doi.org/10.1111/bjh.17526 Zobrazit plný text záznamu Plný text